- Home
- CHE
CHE
Chemed Corp
as 05-30-2025 12:33pm EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 8.8B | IPO Year: | N/A |
| Target Price: | $674.00 | AVG Volume (30 days): | 124.4K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 20.53 | EPS Growth: | 10.48 |
| 52 Week Low/High: | $512.12 - $623.61 | Next Earning Date: | 07-23-2025 |
| Revenue: | $2,488,997,000 | Revenue Growth: | 8.52% |
| Revenue Growth (this year): | 9.53% | Revenue Growth (next year): | 6.08% |
Stock Insider Trading Activity of Chemed Corp (CHE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LEE SPENCER S | CHE | executive vice president | May 7 '25 | Sell | $577.86 | 1,500 | $866,790.00 | 16,127 | |
| MCNAMARA KEVIN J | CHE | president and CEO | May 5 '25 | Sell | $576.45 | 1,500 | $864,675.00 | 101,197 | |
| MCNAMARA KEVIN J | CHE | president and CEO | Mar 31 '25 | Sell | $615.33 | 1,000 | $615,330.00 | 101,197 | |
| MCNAMARA KEVIN J | CHE | president and CEO | Mar 6 '25 | Sell | $593.67 | 2,000 | $1,187,340.00 | 101,197 | |
| LEE SPENCER S | CHE | executive vice president | Mar 3 '25 | Sell | $592.25 | 1,326 | $785,323.50 | 16,127 |
Latest Chemed Corp News
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Zacks
7 days ago
AMED or CHE: Which Is the Better Value Stock Right Now?
Zacks
7 days ago
Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?
StockStory
8 days ago
BrightSpring Health Services (NASDAQ:BTSG) Q1 Earnings: Leading The Senior Health, Home Health & Hospice Pack
Business Wire
11 days ago
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
MT Newswires
11 days ago
Chemed Insider Sold Shares Worth $866,985, According to a Recent SEC Filing
Business Wire
16 days ago
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Simply Wall St.
16 days ago
The total return for Chemed (NYSE:CHE) investors has risen faster than earnings growth over the last five years
Argus Research
17 days ago
CHE: Lowering target price to $613.00
Compare CHE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.